Seminars in Nuclear Medicine
Volume 38, Issue 1 , Pages 82-102 , January 2008

International Scientific Committee of Radionuclides in Nephrourology (ISCORN) Consensus on Renal Transit Time Measurements

  • Emmanuel Durand, MD, PhD

      Affiliations

    • Univ Paris-Sud, Department of Biophysics and Nuclear Medicine, Le Kremlin-Bicêtre, France.
    • Corresponding Author InformationAddress reprint requests to Emmanuel Durand, MD, PhD, Service de Biophysique et Médecine Nucléaire–CHU Bicêtre, 78 rue du Général Leclerc, F94275 Le Kremlin-Bicêtre, France.
    • ,
  • M. Donald Blaufox, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
    • ,
  • Keith E. Britton, MD, MSc, FRCR, FRCP

      Affiliations

    • Department of Nuclear Medicine, St Bartholomew’s Hospital and Barts and the London, Queen Mary School of Medicine and Dentistry, University of London, London, United Kingdom.
    • ,
  • Ove Carlsen, MSc, PhD

      Affiliations

    • Department of Nuclear Medicine, Vejle Hospital, Vejle, Denmark.
    • ,
  • Philip Cosgriff, MSc

      Affiliations

    • Medical Physics Department, Pilgrim Hospital, Boston, Lincolnshire, United Kingdom.
    • ,
  • Eugene Fine, MD, MS

      Affiliations

    • Department of Nuclear Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY.
    • ,
  • John Fleming, PhD

      Affiliations

    • Southampton University Hospitals NHS Trust, Southhampton, United Kingdom.
    • ,
  • Cyril Nimmon, BSc

      Affiliations

    • Department of Nuclear Medicine, St Bartholomew’s Hospital, London, United Kingdom (retired).
    • ,
  • Amy Piepsz, MD, PhD

      Affiliations

    • Centre Hospitalo-Universitaire St Pierre, Brussels, Belgium.
    • ,
  • Alain Prigent, MD, PhD

      Affiliations

    • Univ Paris-Sud, Department of Biophysics and Nuclear Medicine, Le Kremlin-Bicêtre, France.
    • ,
  • Martin Šamal, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, Charles University Prague and the General Teaching Hospital, Prague, Czech Republic.

References 

  1. Taplin GV, Meredith OM, et al. The radioisotope renogram: An external test for individual kidney function and upper urinary tract patency. J Lab Clin Med. 1956;48:886–901[U]
  2. Prigent A, Cosgriff P, Gates GF, et al. Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med. 1999;29:146–159[C3]
  3. Colin F, Mercenier P, Kornreich F, et al. Bases expérimentales d’une interprétation quantitative du rénogramme. Acta Cardiol. 1964;6:546–557[M]
  4. Dore EK, Taplin GV, Johnson DE. Current interpretation of the sodium iodohippurate I-131 renocystogram. JAMA. 1963;185:925–932[U]
  5. Coe FL, Burke G. A Theoretical approach to the I-131-hippuran renogram. J Nucl Med. 1964;5:555–561[M]
  6. Coe FL, Burke G. Renal transit time: Its measurement by the 131-I hippuran renogram. J Nucl Med. 1965;6:269–274[M]
  7. Zierler KL. Equations for measuring blood flow by external monitoring of radioisotopes. Circ Res. 1965;16:309–321[M]
  8. Meldolesi U, Roncari G, Fidanza MA, et al. First attempts of clinical application of a method for the quantitative interpretation of renogram with radiohippuran. J Nucl Biol Med. 1969;13:94–102[U]
  9. Kenny RW, Ackery DM, Fleming JS, et al. Deconvolution analysis of the scintillation camera renogram. Br J Radiol. 1975;48:481–486[C3]
  10. van Stekelenburg LH. Hippuran transit times in the kidney: A new approach. Phys Med Biol. 1978;23:291–301[M]
  11. Peters AM. Fundamentals of tracer kinetics for radiologists. Br J Radiol. 1998;71:1116–1129[O]
  12. Rutland MD. A comprehensive analysis of renal DTPA studies (I. Theory and normal values). Nucl Med Commun. 1985;6:11–20[C3]
  13. Fleming JS, Kemp PM. A comparison of deconvolution and the Patlak-Rutland plot in renography analysis. J Nucl Med. 1999;40:1503–1507[N]
  14. Rutland MD. A comprehensive analysis of renal DTPA studies (II. Renal transplant evaluation). Nucl Med Commun. 1985;6:21–30[U]
  15. Britton K, Nimmon CC. The measurement of renal transit times by deconvolution analysis. In:  Blaufox MD editors. Evaluation of Renal Function and Disease with Radionuclides. (ed 2). Basel, New York: Karger Press; 1989;[O]
  16. Britton KE, Nimmon CC, Whitfield HN, et al. Obstructive nephropathy: Successful evaluation with radionuclides. Lancet. 1979;1:905–907[U]
  17. Britton KE, Nawaz MK, Whitfield HN, et al. Obstructive nephropathy: Comparison between parenchymal transit time index and frusemide diuresis. Br J Urol. 1987;59:127–132[U]
  18. Russell CD, Japanwalla M, Khan S, et al. Renal vascular transit time and tubular transit time dispersion for 99Tcm-MAG3. Nucl Med Commun. 1997;18:832–838[U]
  19. Piepsz A, Ham HR, Erbsmann F, et al. A co-operative study on the clinical value of dynamic renal scanning with deconvolution analysis. Br J Radiol. 1982;55:419–433[C2-2]
  20. Diffey BL, Hall FM, Corfield JR. The 99mTc-DTPA dynamic renal scan with deconvolution analysis. J Nucl Med. 1976;17:352–355[U]
  21. Jones RA, Easley K, Little SB, et al. Dynamic contrast-enhanced MR urography in the evaluation of pediatric hydronephrosis: Part 1, functional assessment. AJR Am J Roentgenol. 2005;185:1598–1607[U]
  22. Bassingthwaighte JB. Circulatory transport and the convolution integral. Mayo Clin Proc. 1967;42:137–154[M]
  23. Erbsmann F, Struyven J, Ham H, et al. Analysis of errors and systemic biases in the calculation of the renal retention function. In:  Brill AB,  Price PR,  McClain WJ editor. Information Processing in Medical Imaging. Oak Ridge National Laboratory Press; 1978;[C3]
  24. Rottman GA, Zhang CG. Precision of mean transit time measurements in 99Tcm-DTPA renal scintigraphy: A Monte Carlo study. Phys Med Biol. 1992;37:1847–1858[N]
  25. Whitaker RH. The Whitaker test. Urol Clin North Am. 1979;6:529–539[O]
  26. Fine EJ. Interventions in renal scintigraphy. Semin Nucl Med. 1991;21:116–127[O]
  27. Chaiwatanarat T, Laorpatanaskul S, Poshyachinda M, et al. Deconvolution analysis of renal blood flow: Evaluation of postrenal transplant complications. J Nucl Med. 1994;35:1792–1796[U]
  28. Brown SC, Upsdell SM, O’Reilly PH. The importance of renal function in the interpretation of diuresis renography. Br J Urol. 1992;69:121–125[C3]
  29. Frokiaer J, Knudsen L, Flo C, et al. Reproducibility of iodine-123-hippuran renoscintigraphy in the normal pig at various flow rates. Scand J Urol Nephrol Suppl. 1989;125:87–93[A]
  30. Rodriguez-Porcel M, Lerman LO, Sheedy PF, et al. Perfusion pressure dependency of in vivo renal tubular dynamics. Am J Physiol. 1997;273:F667–F673[A]
  31. Steele JE, Brand PH, Metting PJ, et al. Dynamic, short-term coupling between changes in arterial pressure and urine flow. Am J Physiol. 1993;265:F717–F722[A]
  32. Keir MJ, Lee RE. The interpretation of renogram curves from the dilated renal tract. Br J Radiol. 1985;58:270–271[C3]
  33. Koff SA, Binkovitz L, Coley B, et al. Renal pelvis volume during diuresis in children with hydronephrosis: Implications for diagnosing obstruction with diuretic renography. J Urol. 2005;174:303–307[C3]
  34. Vivian G, Barratt TM, Todd-Pokropek A, et al. Physiological variations of normal transit time in children. Eur J Nucl Med. 1985;11:179–181[C3]
  35. Jung HS, Chung YA, Kim EN, et al. Influence of hydration status in normal subjects: Fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography. Ann Nucl Med. 2005;19:1–7[C2-2]
  36. Lerman LO, Rodriguez-Porcel M, Sheedy PF, et al. Renal tubular dynamics in the intact canine kidney. Kidney Int. 1996;50:1358–1362[A]
  37. Lerman LO, Rodriguez-Porcel M, Romero JC. The development of x-ray imaging to study renal function. Kidney Int. 1999;55:400–416[A]
  38. Jones RA, Perez-Brayfield MR, Kirsch AJ, et al. Renal transit time with MR urography in children. Radiology. 2004;233:41–50[U]
  39. O’Reilly P, Aurell M, Britton K, et al. Consensus on diuresis renography for investigating the dilated upper urinary tract (Radionuclides in Nephrourology Group. Consensus Committee on Diuresis Renography). J Nucl Med. 1996;37:1872–1876[C3]
  40. Gordon I, Colarinha P, Fettich J, et al. Guidelines for standard and diuretic renography in children. Eur J Nucl Med. 2001;28:BP21–BP30[C3]
  41. Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension (Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography). J Nucl Med. 1996;37:1876–1882[C3]
  42. Blaufox MD, Dubovsky EV, Hilson AJ, et al. Report of the Working Party Group on Determining the Radionuclide of Choice. Am J Hypertens. 1991;4:747S–748S[C3]
  43. Nally JV, Chen C, Fine E, et al. Diagnostic criteria of renovascular hypertension with captopril renography (A consensus statement). Am J Hypertens. 1991;4:749S–752S[C3]
  44. Conway JJ, Maizels M. The “well tempered” diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis (A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council–The Society of Nuclear Medicine). J Nucl Med. 1992;33:2047–2051[C3]
  45. Conway JJ. “Well-tempered” diuresis renography: its historical development, physiological and technical pitfalls, and standardized technique protocol. Semin Nucl Med. 1992;22:74–84[O]
  46. Piepsz A, Hahn K, Roca I, et al. A radiopharmaceuticals schedule for imaging in paediatrics (Paediatric Task Group European Association Nuclear Medicine). Eur J Nucl Med. 1990;17:127–129[C3]
  47. Prvulovich EM, Bomanji JB, Waddington WA, et al. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure. J Nucl Med. 1997;38:809–814[C3]
  48. Gullquist RR, Fleming JS. Error analysis by simulation studies in renography deconvolution. Phys Med Biol. 1987;32:383–395[N]
  49. Cosgriff PS, Lawson RS, Nimmon CC. Towards standardization in gamma camera renography. Nucl Med Commun. 1992;13:580–585[C3]
  50. Kuyvenhoven JD, Ham H, Piepsz A. Is deconvolution applicable to renography?. Nucl Med Commun. 2001;22:1255–1260[B]
  51. Fleming JS. Functional radionuclide imaging of renal mean transit time and glomerular filtration rate. Nucl Med Commun. 1988;9:85–96[U]
  52. Li DJ, Miles KA, Barber RW, et al. Computer-derived regions of interest for the determination of renal parenchymal transit time. Nucl Med Commun. 1993;14:176–180[U]
  53. Lawson RS. Application of mathematical methods in dynamic nuclear medicine studies. Phys Med Biol. 1999;44:R57–R98[M]
  54. Vivian GC, Barratt TM, Todd-Pokropek A, et al. Renal parenchymal determination and analysis during dynamic 99Tcm-DTPA scans in children. Nucl Med Commun. 1984;5:35–40[U]
  55. Samal M, Nimmon CC, Britton KE, et al. Relative renal uptake and transit time measurements using functional factor images and fuzzy regions of interest. Eur J Nucl Med. 1998;25:48–54[M]
  56. Basic M, Popovic S, Mackovic-Basic M, et al. Extravascular background subtraction using deconvolution analysis of the renogram. Phys Med Biol. 1988;33:1065–1073[N]
  57. Kuikka JT, Bassingthwaighte JB, Henrich MM, et al. Mathematical modelling in nuclear medicine. Eur J Nucl Med. 1991;18:351–362[O]
  58. [P] Bell SD, Peters AM. Extravascular chest wall technetium 99m diethylene triamine penta-acetic acid: Implications for the measurement of renal function during renography. Eur J Nucl Med. 1991;18:87–90[P]
  59. Piepsz A, Ham H. Factors influencing the accuracy of renal output efficiency. Nucl Med Commun. 2000;21:1009–1013[N]
  60. Fleming JS. Measurement of Hippuran plasma clearance using a gamma camera. Phys Med Biol. 1977;22:526–530[C3]
  61. Bratt CG, Granerus G. Estimation of renal pelvic dilatation with diuresis renography. In:  Joekes AM,  Constable AR editor. Radionuclides in Nephrology, Vth International Symposium. London: Academic Press; 1982;p. 157–160[R]
  62. Merrick MV, Griffin TM. Evidence for a reflex provoking contraction of the renal pelvis (with some comments on its clinical implications). Eur J Nucl Med. 1994;21:521–524[C3]
  63. Homsy YL, Mehta PH, Huot D, et al. Intermittent hydronephrosis: A diagnostic challenge. J Urol. 1988;140:1222–1226[C3]
  64. Valkema R, Boot CN, Pauwels EK. Sharp peaks in the downslope phase of the diuresis renogram. Semin Nucl Med. 1994;24:350–353[O]
  65. Al-Nahhas A, Marcus AJ, Bomanji J, et al. Validity of the mean parenchymal transit time as a screening test for the detection of functional renal artery stenosis in hypertensive patients. Nucl Med Commun. 1989;10:807–815[U]
  66. Bevis CR, Lawson RS, Shields RA, et al. 99Tcm-TDG renography with deconvolution analysis: a comparative study with 99Tcm-DTPA and 123I-hippuran. Nucl Med Commun. 1984;5:513–517[C3]
  67. Gruenewald SM, Collins LT, Antico VF, et al. Can quantitative renography predict the outcome of treatment of atherosclerotic renal artery stenosis?. J Nucl Med. 1989;30:1946–1954[U]
  68. Gruenewald SM, Stewart JH, Simmons KC, et al. Predictive value of quantitative renography for successful treatment of atherosclerotic renovascular hypertension. Aust N Z J Med. 1985;15:617–622[C2-3]
  69. Mizuiri S, Hayashi I, Takano M, et al. Fractional mean transit time in transplanted kidneys studied by technetium-99m-DTPA: Comparison of clinical and biopsy findings. J Nucl Med. 1994;35:84–89[U]
  70. Jafri RA, Britton KE, Nimmon CC, et al. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J Nucl Med. 1988;29:147–158[C3]
  71. Gonzalez A, Puchal R, Bajen MT, et al. 99Tcm-MAG3 renogram deconvolution in normal subjects and in normal functioning kidney grafts. Nucl Med Commun. 1994;15:680–684[C3]
  72. Russell CD, Yester MV, Dubovsky EV. Measurement of renal parenchymal transit time of 99mTc-MAG3 using factor analysis. Nuklearmedizin. 1990;29:170–176[U]
  73. Carlsen O, Kvinesdal B, Nathan E. Quantitative evaluation of iodine-123 hippuran gamma camera renography in normal children. J Nucl Med. 1986;27:117–127[C3]
  74. Hunter GJ, Gordon I, Sweeney L, et al. 99mTc DTPA scanning with diuretic washout (Is it useful in the investigation of obstruction in the presence of gross renal tract dilatation?). Br J Urol. 1987;59:208–210[U]
  75. Spicer ST, Chi KK, Nankivell BJ, et al. Mercaptoacetyltriglycine diuretic renography and output efficiency measurement in renal transplant patients. Eur J Nucl Med. 1999;26:152–154[C3]
  76. Nankivell BJ, Cohn DA, Spicer ST, et al. Diagnosis of kidney transplant obstruction using Mag3 diuretic renography. Clin Transplant. 2001;15:11–18[U]
  77. Gruenewald SM, Nimmon CC, Nawaz MK, et al. A non-invasive gamma-camera technique for the measurement of intrarenal flow distribution in man. Clin Sci. 1981;61:385–389[C3] (Lond)
  78. Wilkinson SP, Smith IK, Clarke M, et al. Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity, and sodium and water excretion. Clin Sci Mol Med. 1977;52:469–475[C3]
  79. Gruenewald SM, Collins LT. Renovascular hypertension: Quantitative renography as a screening test. Radiology. 1983;149:287–291[U]
  80. Cosgriff P, Berry JM. A comparative assessment of deconvolution and diuresis renography in equivocal upper urinary tract obstruction. Nucl Med Commun. 1982;3:377–384[U]
  81. Houston AS, Whalley DR, Skrypniuk JV, et al. UK audit and analysis of quantitative parameters obtained from gamma camera renography. Nucl Med Commun. 2001;22:559–566[S]
  82. Wong JC, Rossleigh MA, Farnsworth RH. Utility of technetium-99m-MAG3 diuretic renography in the neonatal period. J Nucl Med. 1995;36:2214–2219[C3]
  83. Makoba GI, Nimmon CC, Kouykin V, et al. Comparison of a corticopelvic transfer index with renal transit times. Nucl Med Commun. 1996;17:212–215[U]
  84. Bratt CG, Larsson I, White T. Scintillation camera renography with 99mTc-DTPA and 131I-Hippuran. Scand J Clin Lab Invest. 1981;41:189–197[C3]
  85. Esteves FP, Taylor A, Manatunga A, et al. 99mTc-MAG3 renography: Normal values for MAG3 clearance and curve parameters, excretory parameters and residual urine volume. AJR Am J Roentgenol. 2006;187:W610–W617[C3]
  86. Connolly LP, Zurakowski D, Peters CA, et al. Variability of diuresis renography interpretation due to method of post-diuretic renal pelvic clearance half-time determination. J Urol. 2000;164:467–471[C3]
  87. Piepsz A, Tondeur M, Ham H. NORA: a simple and reliable parameter for estimating renal output with or without frusemide challenge. Nucl Med Commun. 2000;21:317–323[N]
  88. Kuyvenhoven JD, Ham HR, Piepsz A. The influence of renal function on normalized residual activity. Nucl Med Commun. 2004;25:151–154[N]
  89. Piepsz A, Kuyvenhoven JD, Tondeur M, et al. Normalized residual activity: usual values and robustness of the method. J Nucl Med. 2002;43:33–38[U]
  90. Steiner D, Steiss JO, Klett R, et al. The value of renal scintigraphy during controlled diuresis in children with hydronephrosis. Eur J Nucl Med. 1999;26:18–21[U]
  91. Taylor AT, Fletcher JW, Nally JV, et al. Procedure guideline for diagnosis of renovascular hypertension (Society of Nuclear Medicine). J Nucl Med. 1998;39:1297–1302[C3]
  92. Britton K, Brown NJ: The value in obstructive nephropathy of the hippuran output curve derived by computer analysis of the renogram, in. IAEA (ed): The Proceedings of the International Symposium on Dynamic Studies With Radioisotopes in Medicine. Vienna, IAEA, 1971
  93. Chaiwatanarat T, Padhy AK, Bomanji JB, et al. Validation of renal output efficiency as an objective quantitative parameter in the evaluation of upper urinary tract obstruction. J Nucl Med. 1993;34:845–848[U]
  94. Britton K, Brown N. Clinical Renography. London: Llyod-Luke; 1971;[O]
  95. Kuyvenhoven JD, Ham HR, Piepsz A. Influence of renal function on renal output efficiency. J Nucl Med. 2002;43:851–855[N]
  96. Nimmon CC, Samal M, Britton KE. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity. J Nucl Med. 2004;45:587–593[N]
  97. Saunders CA, Choong KK, Larcos G, et al. Assessment of pediatric hydronephrosis using output efficiency. J Nucl Med. 1997;38:1483–1486[U]
  98. [C3] Rado JP, Banos C, Tako J: Radioisotope renography during furosemide (lasix) diuresis. Nucl Med (Stuttg) 7:212-221, 1968 [C3]
  99. O’Reilly PH, Testa HJ, Lawson RS, et al. Diuresis renography in equivocal urinary tract obstruction. Br J Urol. 1978;50:76–80[U]
  100. O’Reilly PH, Lawson RS, Shields RA, et al. Idiopathic hydronephrosis—the diuresis renogram: a new non-invasive method of assessing equivocal pelvioureteral junction obstruction. J Urol. 1979;121:153–155[U]
  101. English PJ, Testa HJ, Lawson RS, et al. Modified method of diuresis renography for the assessment of equivocal pelviureteric junction obstruction. Br J Urol. 1987;59:10–14[U]
  102. Poulsen EU, Frokjaer J, Taagehoj-Jensen F, et al. Diuresis renography and simultaneous renal pelvic pressure in hydronephrosis. J Urol. 1987;138:272–275[C3]
  103. Hunsche A, Press H, Taylor A. Increasing the dose of furosemide in patients with azotemia and suspected obstruction. Clin Nucl Med. 2004;29:149–153[U]
  104. Mandell GA, Cooper JA, Leonard JC, et al. Procedure guideline for diuretic renography in children (Society of Nuclear Medicine). J Nucl Med. 1997;38:1647–1650[C3]
  105. O’Reilly PH. Standardization of the renogram technique for investigating the dilated upper urinary tract and assessing the results of surgery. BJU Int. 2003;91:239–243[O]
  106. Upsdell SM, Testa HJ, Lawson RS. The F-15 diuresis renogram in suspected obstruction of the upper urinary tract. Br J Urol. 1992;69:126–131[U]
  107. Rosenthall L, Tyler JL, Arzoumaniana A. A crossover study comparing delayed radio hippurate images with diuretic renograms. Diagnostic Imaging. 1983;52:267–275[U]
  108. Foda MM, Gatfield CT, Matzinger M, et al. A prospective randomized trial comparing 2 diuresis renography techniques for evaluation of suspected upper urinary tract obstruction in children. J Urol. 1998;159:1691–1693[U]
  109. Turkolmez S, Atasever T, Turkolmez K, et al. Comparison of three different diuretic renal scintigraphy protocols in patients with dilated upper urinary tracts. Clin Nucl Med. 2004;29:154–160[C3]
  110. Upsdell SM, Testa HJ, Lawson RS. The uses and interpretation of modified diuresis renography. In:  Blaufox MD,  Hollenberg NK,  Reynaud C editor. Radionuclides in Nephro-Urology. Basel, Switzerland: Karger; 1990;p. 103–107[R]
  111. Adeyoju AA, Burke D, Atkinson C, et al. The choice of timing for diuresis renography: the F + 0 method. BJU Int. 2001;88:1–5[C2-2]
  112. Donoso G, Kuyvenhoven JD, Ham H, et al. 99mTc-MAG3 diuretic renography in children: a comparison between F0 and F+20. Nucl Med Commun. 2003;24:1189–1193[U]
  113. Camargo EE. Renogram modification caused by furosemide. Nucl Med (Stuttg). 1973;12:240–251[C3]
  114. Koff SA, McDowell GC, Byard M. Diuretic radionuclide assessment of obstruction in the infant: guidelines for successful interpretation. J Urol. 1988;140:1167–1168[C3]
  115. Karam M, Feustel PJ, Goldfarb CR, et al. Diuretic renogram clearance half-times in the diagnosis of obstructive uropathy: Effect of age and previous surgery. Nucl Med Commun. 2003;24:797–807[U]
  116. Thrall JH, Koff SA, Keyes JW. Diuretic radionuclide renography and scintigraphy in the differential diagnosis of hydroureteronephrosis. Semin Nucl Med. 1981;11:89–104[O]
  117. Hjortso E, Fugleberg S, Nielsen L, et al. Diuresis renography in patients with reduced renal function. Dan Med Bull. 1988;35:294–295[C3]
  118. Kletter K, Nurnberger N. Diagnostic potential of diuresis renography: Limitations by the severity of hydronephrosis and by impairment of renal function. [C3] Nucl Med Commun. 1989;10:51–61
  119. Upsdell SM, Leeson SM, Brooman PJ, et al. Diuretic-induced urinary flow rates at varying clearances and their relevance to the performance and interpretation of diuresis renography. Br J Urol. 1988;61:14–18[C3]
  120. Karacalioglu O, Ilgan S, Arslan N, et al. Unilateral temporary functional stasis in the upper urinary tract caused by “a filled bladder” on Tc-99m DTPA diuresis renography: A teaching case. Ann Nucl Med. 2005;19:511–514[C3]
  121. Donoso G, Ham H, Tondeur M, et al. Influence of early furosemide injection on the split renal function. Nucl Med Commun. 2003;24:791–795[C2-3]
  122. Koff SA. Pathophysiology of ureteropelvic junction obstruction (Clinical and experimental observations). Urol Clin North Am. 1990;17:263–272[O]
  123. Koff SA, Shore RM. Diuretic radionuclide urography. Urol Radiol. 1983;5:189–195197, [O]
  124. Neal DE, Simpson W, Bartholomew P, et al. Comparison of dynamic computed tomography, diuresis renography and DTPA parenchymal transit time in the assessment of dilatation of the upper urinary tract. Br J Urol. 1985;57:515–519[C3]
  125. Donohoe K. Caution in the use of volume expansion diuretic renal scan. J Nucl Med. 1988;29:133–134[L]
  126. Gordon I, Mialdea-Fernandez RM, Peters AM. Pelviureteric junction obstruction (The value of a post-micturition view in 99mTc DTPA diuretic renography). [U] Br J Urol. 1988;61:409–412[U]
  127. Smyth TB, Shortliffe LM, Constantinou CE. The effect of urinary flow and bladder fullness on renal pelvic pressure in a rat model. J Urol. 1991;146:592–596[A]
  128. Jones DA, Lupton EW, George NJ. Effect of bladder filling on upper tract urodynamics in man. Br J Urol. 1990;65:492–496[C2-3]
  129. Greenstein A, Chen J, Matzkin H, et al. Potential pitfalls in the obstructive renal scan in patients with double-pigtail ureteral catheters. J Urol. 1989;141:283–284[C2-3]
  130. Rossleigh MA, Leighton DM, Farnsworth RH. Diuresis renography (The need for an additional view after gravity-assisted drainage). Clin Nucl Med. 1993;18:210–213[U]
  131. Gill WB, Curtis GA. The influence of bladder fullness on upper urinary tract dimensions and renal excretory function. J Urol. 1977;117:573–576[C3]
  132. Pierce JM, Braun E. Ureteral response to elevated intravesical pressures in humans. Surg Forum. 1960;11:482–484[U]
  133. Koff SA. Problematic ureteropelvic junction obstruction. J Urol. 1987;138:390;[O]
  134. Peters CA. Urinary tract obstruction in children. J Urol. 1995;154:1874–1883discussion 1883-1874, [O]
  135. Bratt CG, Aurell M, Jonsson O, et al. Long-term followup of maximum concentrating ability and glomerular filtration rate in adult obstructed kidneys after pyeloplasty. J Urol. 1988;140:273–276[C2-2]
  136. Kekomaki M, Rikalainen H, Ruotsalainen P, et al. Correlates of diuretic renography in experimental hydronephrosis. J Urol. 1989;141:391–394[A]
  137. Jones DA, George NJ, O’Reilly PH. Postobstructive renal function. Semin Urol. 1987;5:176–190
  138. Frokiaer J. Obstructive nephropathy in the pig (Aspects of renal hemodynamics and hormonal changes during acute unilateral ureteral obstruction). [A] APMIS Suppl. 1998;82:7–48[A]
  139. Underwood W. Recent observations on pathology of hydronephrosis. Proc R soc Med. 1937;30:817–826[C3]
  140. Johnston JH. The pathogenesis of hydronephrosis in children. Br J Urol. 1969;41:724–734[U]
  141. Djurhuus JC, Frokiaer J, Jorgensen TM, et al. Methods of diagnosing ureteral obstruction. Semin Urol. 1987;5:192–196[O]
  142. Holden D, George NJ, Rickards D, et al. Renal pelvic pressures in human chronic obstructive uropathy. Br J Urol. 1984;56:565–570[C3]
  143. Tripp BM, Homsy YL. Neonatal hydronephrosis—the controversy and the management. [O] Pediatr Nephrol. 1995;9:503–509[O]
  144. Koff SA. The diagnosis of obstruction in experimental hydroureteronephrosis (Mechanisms for progressive urinary tract dilation). Invest Urol. 1981;19:85–88[A]
  145. Rector FC, Brunner FP, Seldin DW. Mechanism of glomerulotubular balance (I. Effect of aortic constriction and elevated ureteropelvic pressure on glomerular filtration rate, fractional reabsorption, transit time, and tubular size in the proximal tubule of the rat). J Clin Invest. 1966;45:590–602[A]
  146. Rajabi H, Pant GS. Optimum filtration for time-activity curves in nuclear medicine. Nucl Med Commun. 2000;21:823–828[N]
  147. Huang WY, Peters CA, Zurakowski D, et al. Renal biopsy in congenital ureteropelvic junction obstruction: Evidence for parenchymal maldevelopment. Kidney Int. 2006;69:137–143[P]
  148. Frokiaer J, Jensen FT, Djurhuus JC, et al. The impact of unilateral ureteral obstruction on pelvic and parenchymal transit times in the pig kidney. Eur J Nucl Med. 1990;16:349–352[A]
  149. Provoost AP, Van Aken M, Molenaar JC. Sequential renography and renal function in Brown-Norway rats with congenital hydronephrosis. J Urol. 1991;146:588–591[A]
  150. Piepsz A, Ham HR, Collier F, et al. Sensitivity of cortical transit and furosemide response in the diagnosis of renal obstruction (An experimental model). Uremia Invest. 1985;9:245–252[A]
  151. Harving N, Christiansen P, Taagehoj-Jensen F, et al. Experimental evaluation of furosemide renography in unobstructed and partially obstructed upper urinary tracts in pigs. Urology. 1991;37:590–594[A]
  152. Whitaker RH. Methods of assessing obstruction in dilated ureters. Br J Urol. 1973;45:15–22[U]
  153. Witherow RO, Whitaker RH. The predictive accuracy of antegrade pressure flow studies in equivocal upper tract obstruction. Br J Urol. 1981;53:496–499[U]
  154. Ryan PC, Maher K, Hurley GD, et al. The Whitaker test: Experimental analysis in a canine model of partial ureteric obstruction. J Urol. 1989;141:387–390[A]
  155. Fung LC, Khoury AE, McLorie GA, et al. Evaluation of pediatric hydronephrosis using individualized pressure flow criteria. J Urol. 1995;154:671–676[U]
  156. Djurhuus JC, Sorensen SS, Jorgensen TM, et al. Predictive value of pressure flow studies for the functional outcome of reconstructive surgery for hydronephrosis. Br J Urol. 1985;57:6–9[C2-2]
  157. Woodbury PW, Mitchell ME, Scheidler DM, et al. Constant pressure perfusion: A method to determine obstruction in the upper urinary tract. J Urol. 1989;142:632–635discussion 667-638, [A]
  158. Kass EJ, Majd M, Belman AB. Comparison of the diuretic renogram and the pressure perfusion study in children. J Urol. 1985;134:92–96[U]
  159. Dhillon HK. Prenatally diagnosed hydronephrosis: The Great Ormond Street experience. Br J Urol. 1998;81 Suppl 2:39–44[C2-2]
  160. Wahlin N, Magnusson A, Persson AE, et al. Pressure flow measurement of hydronephrosis in children: A new approach to definition and quantification of obstruction. J Urol. 2001;166:1842–1847[U]
  161. Josephson S. Antenatally detected, unilateral dilatation of the renal pelvis: A critical review. 2 (Postnatal non-operative treatment—long-term hazards, urgent research). Scand J Urol Nephrol. 2002;36:251–259[O]
  162. Lupton EW, Richards D, Testa HJ, et al. A comparison of diuresis renography, the Whitaker test and renal pelvic morphology in idiopathic hydronephrosis. Br J Urol. 1985;57:119–123[C3]
  163. Hanna MK, Jeffs RD, Sturgess JM, et al. Ureteral structure and ultrastructure (Part II: Congenital ureteropelvic junction obstruction and primary obstructive megaureter). J Urol. 1976;116:725–730[C3]
  164. Gosling JA, Dixon JS. Functional obstruction of the ureter and renal pelvis (A histological and electron microscopic study). Br J Urol. 1978;50:145–152[C3]
  165. Eskild-Jensen A, Gordon I, Piepsz A, et al. Congenital unilateral hydronephrosis: A review of the impact of diuretic renography on clinical treatment. J Urol. 2005;173:1471–1476[O]
  166. Nguyen HT, Kogan BA. Upper urinary tract obstruction: Experimental and clinical aspects. Br J Urol. 1998;81(suppl 2):13–21[O]
  167. King LR, Coughlin PW, Bloch EC, et al. The case for immediate pyeloplasty in the neonate with ureteropelvic junction obstruction. J Urol. 1984;132:725–728[U]
  168. Ulman I, Jayanthi VR, Koff SA. The long-term follow up of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J Urol. 2000;164:1101–1105[C2-2]
  169. Koff SA, Campbell KD. The nonoperative management of unilateral neonatal hydronephrosis: Natural history of poorly functioning kidneys. J Urol. 1994;152:593–595[C2-2]
  170. Koff SA, Campbell K. Nonoperative management of unilateral neonatal hydronephrosis. J Urol. 1992;148:525–531[C2-2]
  171. Freedman ER, Rickwood AM. Prenatally diagnosed pelviureteric junction obstruction: A benign condition?. J Pediatr Surg. 1994;29:769–772[U]
  172. Subramaniam R, Kouriefs C, Dickson AP. Antenatally detected pelvi-ureteric junction obstruction: Concerns about conservative management. BJU Int. 1999;84:335–338[C2-2]
  173. Dejter SW, Eggli DF, Gibbons MD. Delayed management of neonatal hydronephrosis. J Urol. 1988;140:1305–1309[C2-2]
  174. Ransley PG, Dhillon HK, Gordon I, et al. The postnatal management of hydronephrosis diagnosed by prenatal ultrasound. J Urol. 1990;144:584–587discussion 593-584, [U]
  175. Palmer LS, Maizels M, Cartwright PC, et al. Surgery versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: A report from the Society for Fetal Urology. J Urol. 1998;159:222–228[C1]
  176. Ylinen E, Ala-Houhala M, Wikstrom S. Outcome of patients with antenatally detected pelviureteric junction obstruction. Pediatr Nephrol. 2004;19:880–887[U]
  177. McAleer IM, Kaplan GW. Renal function before and after pyeloplasty: Does it improve?. J Urol. 1999;162:1041–1044[U]
  178. Chertin B, Fridmans A, Knizhnik M, et al. Does early detection of ureteropelvic junction obstruction improve surgical outcome in terms of renal function?. J Urol. 1999;162:1037–1040[U]
  179. Capolicchio G, Leonard MP, Wong C, et al. Prenatal diagnosis of hydronephrosis: Impact on renal function and its recovery after pyeloplasty. J Urol. 1999;162:1029–1032[U]
  180. Cornford PA, Rickwood AM. Functional results of pyeloplasty in patients with ante-natally diagnosed pelvi-ureteric junction obstruction. Br J Urol. 1998;81:152–155[U]
  181. Takla NV, Hamilton BD, Cartwright PC, et al. Apparent unilateral ureteropelvic junction obstruction in the newborn: Expectations for resolution. J Urol. 1998;160:2175–2178[U]
  182. MacNeily AE, Maizels M, Kaplan WE, et al. Does early pyeloplasty really avert loss of renal function? A retrospective review. J Urol. 1993;150:769–773[U]
  183. Salem YH, Majd M, Rushton HG, et al. Outcome analysis of pediatric pyeloplasty as a function of patient age, presentation and differential renal function. J Urol. 1995;154:1889–1893[U]
  184. Kempi V, Sutton DG. Estimating the diagnostic yields resulting from renography and deconvolution parameters: A logistic regression analysis. J Nucl Med. 1995;36:147–152[N]
  185. Lupton EW, Testa HJ, O’Reilly PH, et al. Diuresis renography and morphology in upper urinary tract obstruction. Br J Urol. 1979;51:10–14[C3]
  186. English PJ, Testa HJ, Gosling JA, et al. Idiopathic hydronephrosis in childhood—a comparison between diuresis renography and upper urinary tract morphology. Br J Urol. 1982;54:603–607[U]
  187. Hay AM, Norman WJ, Rice ML, et al. A comparison between diuresis renography and the Whitaker test in 64 kidneys. Br J Urol. 1984;56:561–564[C3]
  188. Whitaker RH, Buxton-Thomas MS. A comparison of pressure flow studies and renography in equivocal upper urinary tract obstruction. J Urol. 1984;131:446–449[U]
  189. Gonzalez R, Chiou R. The diagnosis of upper urinary tract obstruction in children: Comparison of diuresis renography and pressure flow studies. J Urol. 1985;133:646–649[U]
  190. O’Reilly P. Nuclear medicine in urology—an update. Contrib Nephrol. 1987;56:215–224[O]
  191. Pawar HN, Abdel-Dayem HM. Diuretic renography and urodynamic pressure studies in evaluating dilated bilharzial ureters (A preliminary report). Clin Nucl Med. 1984;9:402–404[C3]
  192. Dacher J, Pfister C, Thoumas D, et al. Shortcomings of diuresis scintigraphy in evaluating urinary obstruction: Comparison with pressure flow studies. Pediatr Radiol. 1999;29:742–747[C3]
  193. Lupton EW, Holden D, George NJ, et al. Pressure changes in the dilated upper urinary tract on perfusion at varying flow rates. Br J Urol. 1985;57:622–624[C3]
  194. Nauta J, Pot DJ, Kooij PP, et al. Forced hydration prior to renography in children with hydronephrosis (An evaluation). Br J Urol. 1991;68:93–97[C2-2]
  195. Verboven M, Achten R, Keuppens F, et al. Radioisotopic transit parameters in obstruction of pelviureteral junction. Urology. 1988;32:370–374[U]
  196. Josephson S. Antenatally detected, unilateral dilatation of the renal pelvis: a critical review. 1 (Postnatal non-operative treatment 20 years on—is it safe?). Scand J Urol Nephrol. 2002;36:243–250[O]
  197. Piepsz A, Biggi A, Sixt R, et al. Symposium on radionuclides in paediatric nephro-urology. Nucl Med Commun. 2003;24:11–22[O]
  198. Dondi M, Fanti S, De Fabritiis A, et al. Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med. 1992;33:2040–2044[C2-2]
  199. Fommei E, Ghione S, Hilson AJ, et al. Captopril radionuclide test in renovascular hypertension: A European multicentre study (European Multicentre Study Group). Eur J Nucl Med. 1993;20:617–623[C2-2]
  200. Blaufox MD, Fine EJ, Heller S, et al. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography (The Einstein/Cornell Collaborative Hypertension Group). J Nucl Med. 1998;39:522–528[C2-2]
  201. Datseris IE, Bomanji JB, Brown EA, et al. Captopril renal scintigraphy in patients with hypertension and chronic renal failure. [U] J Nucl Med. 1994;35:251–254[U]
  202. Russell CD, Japanwalla M, Khan S, et al. Techniques for measuring renal transit time. Eur J Nucl Med. 1995;22:1372–1378
  203. Rutland MD, Stuart RA. A comprehensive analysis of renal DTPA studies (III. Renal artery stenosis). Nucl Med Commun. 1986;7:879–885[U]
  204. Dondi M, Monetti N, Fanti S, et al. Use of technetium-99m-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition. J Nucl Med. 1991;32:424–428[C2-2]
  205. Dondi M, Franchi R, Levorato M, et al. Evaluation of hypertensive patients by means of captopril enhanced renal scintigraphy with technetium-99m DTPA. J Nucl Med. 1989;30:615–621[C2-2]
  206. Fine EJ, Li Y, Blaufox MD. Parenchymal mean transit time analysis of 99mTc-DTPA captopril renography. J Nucl Med. 2000;41:1627–1631[U]
  207. Bajen MT, Puchal R, Gonzalez A, et al. MAG3 renogram deconvolution in kidney transplantation: Utility of the measurement of initial tracer uptake. J Nucl Med. 1997;38:1295–1299[U]
  208. Diffey BL, Hall FM, Piepsz A, et al. Renal deconvolution and the poor injection. Eur J Nucl Med. 1978;3:145–146[C3]
  209. Aigner RM, O’Mara RE, Fueger GF, et al. Renography before heart transplantation in patients with cardiomyopathy. J Nucl Med. 1998;39:2153–2158[C3]
  210. The periodic health examination: 2. 1987 update (Canadian Task Force on the Periodic Health Examination). CMAJ. 1988;138:618–626[C3]
  211. Hayward R, Wilson MC, Tunis SR, et al: How to use a clinical practice guideline. Available from: http://www.cche.net/usersguides/guideline.asp

 Note: Throughout the text, the symbol “±” stands for standard deviation.

 Conflicts of interest: K.E.B. was a consultant to Nuclear Diagnostics Ltd (Hermes work stations) from October 2004 to October 2005; he is no longer involved with this company.

 The publication of this paper was made possible by a grant from ISCORN (A. Prigent) and contributions from A.T. Taylor and M.D. Blaufox.

PII: S0001-2998(07)00115-8

doi: 10.1053/j.semnuclmed.2007.09.009

Seminars in Nuclear Medicine
Volume 38, Issue 1 , Pages 82-102 , January 2008

Article Tools

* Image Usage & Resolution